Related Experiment Video
Updated: May 9, 2025
03:55
Author Spotlight: FISH as a Tool for Precise Gene Amplification Assessment in Cancer Specimens
Published on: July 12, 2024
1.1K
Precision Detection of FGFR2b Protein Expression in Solid Tumors
Autumn Sky Watson1, Catherine Le1, Anne Wertheimer1
1From PHCS Assay Development, Roche Diagnostics Solutions, Tucson, Arizona(Watson, Le, Wertheimer, Escobedo, So, Siddegowda, Palting).
Archives of Pathology & Laboratory Medicine
|May 6, 2025
Summary
Optimizing immunohistochemistry protocols for fibroblast growth factor receptor 2b (FGFR2b) staining is crucial for accurately assessing diverse tumors. Tailored protocols enhance assay sensitivity and specificity across various cancer types.
Area of Science:
- Oncology
- Pathology
- Biochemistry
Background:
- Fibroblast growth factor receptor 2b (FGFR2b) expression is heterogeneous across tumor types.
- Tissue type and fixation methods significantly affect FGFR2b antigen accessibility in FFPE specimens.
- Automated staining platforms require optimized parameters for reliable assay sensitivity.
Purpose of the Study:
- To optimize the VENTANA FGFR2b (FPR2-D) assay for non-small cell lung cancer (NSCLC) and other solid tumors.
- To adapt an assay initially validated for gastric and gastroesophageal junction (G/GEJ) adenocarcinoma.
Main Methods:
- Developed and evaluated multiple FGFR2b assay protocols on FFPE tissue from 10 tumor types.
- Selected optimal protocol parameters for strong, specific staining with minimal background.
- Assessed assay sensitivity, specificity, and repeatability.
Main Results:
- Established distinct immunohistochemistry protocols optimized for specific tumor types.
- One protocol was tailored for G/GEJ adenocarcinoma, another for NSCLC and broader solid tumors.
- Parameter screening is vital for effective FGFR2b evaluation across different tumor histologies.
Conclusions:
- Optimized FGFR2b staining protocols are essential for accurate assessment in diverse cancers.
- Tailoring protocols to specific tumor types improves assay performance.
- This work highlights the importance of parameter optimization in immunohistochemistry assays.
